ASCI: 60 of 61 nutraceutical ads broke code
ASCI reviewed 61 nutraceutical ads and found all 60 concluded cases violated its code. Here's the psychology and the compliance lesson for marketers.
India’s advertising watchdog has delivered a sharp wake-up call to health and wellness marketers. In its newly released report, A Pill for Thought: Review of Health and Wellness Claims in Nutraceutical Advertising, the Advertising Standards Council of India (ASCI) reviewed 61 nutraceutical advertisements that ran between July and September 2026. One case is still under process. All 60 concluded cases were found to violate the ASCI Code.
For a category built on trust, that is less a red flag than a siren.
The gap between ingredient and product
ASCI’s central finding is not that marketers fabricate research. It is that many borrow credibility from an ingredient and stretch it over an entire formulation. A study on, say, a botanical extract may be real, but it does not automatically prove that a finished capsule, at its specific dose and combination, delivers the advertised benefit.
“Research on an individual ingredient cannot automatically be used to substantiate the efficacy of a finished product,” said Manisha Kapoor, CEO and secretary general, ASCI.
The report highlighted claims such as “Lose 6 kgs in 60 days”, “Your thigh fat will be gone in 12 weeks” and “300% stronger skin defence against UV damage”. These are not just words; they are promises with numbers, timelines and visual before-and-after proof.
Three recurring patterns
The violations spanned weight management, anti-ageing, skin lightening, UV protection and respiratory health, including claims around asthma, COPD, blood pressure, cholesterol and PCOS. ASCI identified three ways these claims ran off the rails:
- Claims made without adequate clinical evidence or independent test reports.
- Comparative claims like “faster” or “more effective” without a clear, substantiated benchmark.
- Promises of benefits that advertisers could not support when challenged.
Notably, 29 advertisers did not contest the objections, while 31 failed to provide adequate evidence. In several cases, advertisers chose to withdraw or modify their ads rather than defend the claims.
Why this matters for brand managers
Nutraceuticals are expanding fast: functional foods, beverages and dietary supplements are increasingly part of everyday consumption. Advertising does the heavy lifting of shaping what buyers expect. When claims run ahead of evidence, the brand pays in regulatory action today and in consumer scepticism tomorrow.
The psychology is familiar. Specific figures like “6 kgs in 60 days” carry a precision bias. Before-after visuals trigger a transformation heuristic. Ingredient stories borrow the authority of clinical science. Each works in the short term; each also raises the burden of proof.
The practical takeaway is simple: run the same discipline at product level. If you cannot show evidence for the finished formulation, soften the claim, adjust the comparison or pull the visual. A smaller honest promise compounds more trust than a big unsupported one. ASCI has also published a list of cases processed as part of the review.
Source: Afaqs!
